OnSite® COVID-19 Ag Rapid Test Treatment Consumables

Validated for Alpha (U.K.), Beta (South Africa), Gamma (Brazil), Delta (India), Eta (Nigeria), Iota (USA), Kappa (India), Lambda (Peru), P.2 (Brazil), B.1.620 and Omicron variants detection.

Options for either a nasal or nasopharyngeal swabs. 

Improved detection line, which has a LoD of 40 TCID50/mL, this implies that tests can detect fewer viruses and the kit’s sensitivity is 97.6%. 

According to TGA, the kit has been rated as “very highly sensitive”

Product Features:

• Supports patient management decisions by detecting viral components within first seven days of symptom onset
• Sample collection made easier through nasal swab procedure for patient comfort and end-user flexibility
• Pre-filled extraction tubes simplify test procedure
• 94.7% Sensitivity; 100% Specificity
• Fast results in 15-20 minutes
• Easy to use in point-of-care & resource-limited settings
• Compatible with CT's ALTA® Rapid Test Reader (RTR-1)